TWC
MRNA icon

TD Waterhouse Canada’s Moderna MRNA Stock Holding History

TD Waterhouse Canada’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
3,388
+85
+3% +$4.4K ﹤0.01% 1030
2026
Q1 		$165K Buy
3,303
+3,039
+1,151% +$142K ﹤0.01% 1082
2025
Q4 		$7.79K Sell
264
-534
-67% -$14.5K ﹤0.01% 1604
2025
Q3 		$22K Sell
798
-1,015
-56% -$28.3K ﹤0.01% 1364
2025
Q2 		$52K Buy
1,813
+980
+118% +$25.8K ﹤0.01% 1112
2025
Q1 		$22.6K Sell
833
-2,555
-75% -$90.7K ﹤0.01% 1244
2024
Q4 		$141K Buy
3,388
+308
+10% +$14.7K ﹤0.01% 868
2024
Q3 		$197K Sell
3,080
-3,022
-50% -$277K ﹤0.01% 776
2024
Q2 		$707K Sell
6,102
-270
-4% -$34.2K 0.01% 538
2024
Q1 		$683K Buy
6,372
+566
+10% +$57.1K 0.01% 564
2023
Q4 		$647K Sell
5,806
-735
-11% -$61.8K 0.01% 500
2023
Q3 		$696K Buy
6,541
+402
+7% +$44.8K 0.01% 472
2023
Q2 		$765K Buy
6,139
+875
+17% +$117K 0.01% 455
2023
Q1 		$869K Sell
5,264
-86
-2% -$14.2K 0.01% 437
2022
Q4 		$983K Sell
5,350
-719
-12% -$118K 0.01% 411
2022
Q3 		$752K Sell
6,069
-199
-3% -$30.2K 0.01% 442
2022
Q2 		$979K Sell
6,268
-771
-11% -$110K 0.01% 414
2022
Q1 		$1.28M Sell
7,039
-176
-2% -$29.6K 0.01% 403
2021
Q4 		$1.74M Buy
+7,215
New +$2.11M 0.02% 391

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

TD Waterhouse Canada's MRNA Position: Q2 2026 in Review

TD Waterhouse Canada increased its Moderna (MRNA) stake by 2.6% in Q2 2026, buying an estimated $4.4K and bringing the position to 3,388 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

TD Waterhouse Canada first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.74M in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • TD Waterhouse Canada held 3,388 shares of Moderna worth $246K as of Q2 2026.
  • TD Waterhouse Canada bought 85 Moderna shares in Q2 2026, an estimated $4.4K.
  • Moderna made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1030 holding.
  • TD Waterhouse Canada first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Moderna position peaked at $1.74M in Q4 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.